amycretin oral (NN9487 oral) / Novo Nordisk  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amycretin oral (NN9487 oral) / Novo Nordisk
NCT06049329: A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity

Completed
1
36
Japan
NNC0487-0111, Placebo (NNC0487-0111)
Novo Nordisk A/S
Obesity
12/23
12/23
NCT05369390: A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity

Completed
1
144
US
NNC0487-0111 A, NNC0487-0111 B, Placebo B (NNC0487-0111 B), Placebo A (NNC0487-0111 A)
Novo Nordisk A/S
Obesity
01/24
01/24

Download Options